{
    "medicine_id": "b11d739f02ad6f73ff2ffbcbefb402c18673b3e9",
    "platform_id": "DB00934",
    "metadata": {
        "name": "Ludiomil 25 mg 1 Tablet",
        "composition": "25 mg 1 Maprotiline",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of depression including the depressed phase of bipolar depression psychotic depression and involutional melancholia and may also be helpful in treating certain patients suffering severe depressive neurosis",
            "contraindications": {
                "disease": "LD sub 50 sub 900 mg kg Orally in rats LD sub 50 sub 90 mg kg Orally in women Signs of overdose include motor unrest muscular twitching and rigidity tremor ataxia convulsions hyperpyrexia vertigo mydriasis vomiting cyanosis hypotension shock tachycardia cardiac arrhythmias impaired cardiac conduction respiratory depression and disturbances of consciousness up to deep coma",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Maprotiline is a tetracyclic antidepressant Although its main therapeutic use is in the treatment of depression it has also been shown to exert a sedative effect on the anxiety component that often accompanies depression In one sleep study it was shown that maprotiline increases the duration of the REM sleep phase in depressed patients compared to imipramine which reduced the REM sleep phase Maprotiline is a strong inhibitor of noradrenaline reuptake in the brain and peripheral tissues however it is worthy to note that it is a weak inhibitor of serotonergic uptake In addition it displays strong antihistaminic action which may explain its sedative effects as well as weak anticholinergic action Maprotiline also has lower alpha adrenergic blocking activity than amitriptyline",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB01609",
                        "description": "The serum concentration of Maprotiline can be increased when it is combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The serum concentration of Maprotiline can be increased when it is combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The serum concentration of Maprotiline can be decreased when it is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The serum concentration of Maprotiline can be decreased when it is combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Hydrocodone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Maprotiline can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Maprotiline may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Maprotiline may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Maprotiline may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Maprotiline may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Aclidinium"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "Maprotiline may increase the anticholinergic activities of Mianserin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of urinary retention can be increased when Maprotiline is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "The risk or severity of gastrointestinal ulceration can be increased when Maprotiline is combined with Potassium chloride"
                    },
                    {
                        "drugbank-id": "DB01278",
                        "description": "The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09527",
                        "description": "The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tiotropium"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of hyperthermia and oligohydrosis can be increased when Maprotiline is combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB00895",
                        "description": "Maprotiline may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB06698",
                        "description": "The therapeutic efficacy of Betahistine can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00070",
                        "description": "The therapeutic efficacy of Hyaluronidase ovine can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06205",
                        "description": "The therapeutic efficacy of Hyaluronidase human recombinant can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14740",
                        "description": "The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Rasagiline is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Pargyline is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Hydracarbazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Benmoxin is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Mebanazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Octamoxin is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Pheniprazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Phenoxypropazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Pivhydrazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Safrazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Caroxazone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Harmaline is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Brofaromine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Safinamide is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Phenelzine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The serum concentration of Maprotiline can be increased when it is combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum toxin type A"
                    },
                    {
                        "drugbank-id": "DB00040",
                        "description": "Maprotiline may increase the gastrointestinal motility reducing activities of Glucagon"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "Sulpiride may increase the anticholinergic activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum Toxin Type B"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Maprotiline may increase the serotonergic activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of constipation can be increased when Maprotiline is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of constipation can be increased when Maprotiline is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The metabolism of Maprotiline can be increased when combined with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of adverse effects can be increased when Citalopram is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Phentermine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "Pseudoephedrine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lisdexamfetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mephentermine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "2 5 Dimethoxy 4 ethylamphetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Chlorphentermine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Methylenedioxyethamphetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Dextroamphetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Iofetamine I 123 may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Ritobegron may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mephedrone may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Methoxyphenamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Gepefrine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may decrease the sedative and stimulatory activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Diamorphine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Desomorphine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of adverse effects can be increased when Naltrexone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Codeine"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Fentanyl"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Meperidine"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Benzhydrocodone"
                    },
                    {
                        "drugbank-id": "DB00809",
                        "description": "The risk or severity of adverse effects can be increased when Tropicamide is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00979",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Cyclopentolate"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01161",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Chloroprocaine"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01496",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dihydro 2 thioxo 5 5 2 trifluoromethyl phenyl 2 furanyl methyl 4 6 1H 5H pyrimidinedione"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Agmatine"
                    },
                    {
                        "drugbank-id": "DB11181",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Homatropine"
                    },
                    {
                        "drugbank-id": "DB09271",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Cimetropium"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Maprotiline may increase the serotonergic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB06704",
                        "description": "Maprotiline can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB00527",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Cinchocaine"
                    },
                    {
                        "drugbank-id": "DB00545",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Pyridostigmine"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Nizatidine"
                    },
                    {
                        "drugbank-id": "DB00677",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Isoflurophate"
                    },
                    {
                        "drugbank-id": "DB00711",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Diethylcarbamazine"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00944",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Demecarium"
                    },
                    {
                        "drugbank-id": "DB00981",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Physostigmine"
                    },
                    {
                        "drugbank-id": "DB00989",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Rivastigmine"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Edrophonium"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Memantine"
                    },
                    {
                        "drugbank-id": "DB01122",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Ambenonium"
                    },
                    {
                        "drugbank-id": "DB01381",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Ginkgo biloba"
                    },
                    {
                        "drugbank-id": "DB01400",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Neostigmine"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Bambuterol"
                    },
                    {
                        "drugbank-id": "DB02365",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with 1 10 Phenanthroline"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04864",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Huperzine A"
                    },
                    {
                        "drugbank-id": "DB04892",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Phenserine"
                    },
                    {
                        "drugbank-id": "DB05386",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Regramostim"
                    },
                    {
                        "drugbank-id": "DB06692",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Aprotinin"
                    },
                    {
                        "drugbank-id": "DB06756",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Glycine betaine"
                    },
                    {
                        "drugbank-id": "DB11473",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Metrifonate"
                    },
                    {
                        "drugbank-id": "DB12482",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Acotiamide"
                    },
                    {
                        "drugbank-id": "DB13058",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Methanesulfonyl Fluoride"
                    },
                    {
                        "drugbank-id": "DB13495",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Paraoxon"
                    },
                    {
                        "drugbank-id": "DB13503",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Tyrothricin"
                    },
                    {
                        "drugbank-id": "DB13668",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Ipidacrine"
                    },
                    {
                        "drugbank-id": "DB13694",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Distigmine"
                    },
                    {
                        "drugbank-id": "DB14031",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Tretamine"
                    },
                    {
                        "drugbank-id": "DB15317",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Posiphen"
                    },
                    {
                        "drugbank-id": "DB02845",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Methylphosphinic Acid"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The therapeutic efficacy of Magnesium cation can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "The therapeutic efficacy of Zinc can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04816",
                        "description": "The therapeutic efficacy of Dantron can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04823",
                        "description": "The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04824",
                        "description": "The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB07715",
                        "description": "The therapeutic efficacy of Emodin can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08890",
                        "description": "The therapeutic efficacy of Linaclotide can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09311",
                        "description": "The therapeutic efficacy of Polycarbophil can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The therapeutic efficacy of Monopotassium phosphate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "The therapeutic efficacy of Dipotassium phosphate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The therapeutic efficacy of Glycerin can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "The therapeutic efficacy of Mineral oil can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11059",
                        "description": "The therapeutic efficacy of Carboxymethylcellulose can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11089",
                        "description": "The therapeutic efficacy of Docusate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11097",
                        "description": "The therapeutic efficacy of Plantago seed can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11113",
                        "description": "The therapeutic efficacy of Castor oil can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The therapeutic efficacy of Magnesium glycinate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11228",
                        "description": "The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11365",
                        "description": "The therapeutic efficacy of Sennosides can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The therapeutic efficacy of Lactitol can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13170",
                        "description": "The therapeutic efficacy of Plecanatide can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The therapeutic efficacy of Magnesium peroxide can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The therapeutic efficacy of Pentaerithrityl can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14232",
                        "description": "The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The therapeutic efficacy of Sodium ascorbate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The therapeutic efficacy of Sodium phosphate monobasic unspecified form can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The therapeutic efficacy of Sodium phosphate dibasic unspecified form can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The therapeutic efficacy of Magnesium can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14585",
                        "description": "The therapeutic efficacy of Plantago ovata seed can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14627",
                        "description": "The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14963",
                        "description": "The therapeutic efficacy of Konjac mannan can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB15477",
                        "description": "The therapeutic efficacy of Alloin can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB15478",
                        "description": "The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The therapeutic efficacy of Sodium cation can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The therapeutic efficacy of Sulfate ion can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Profenamine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Gallamine triethiodide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "Hexafluronium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Tubocurarine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "Ketamine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "Decamethonium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Pancuronium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Pipecuronium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Baclofen may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "Ethchlorvynol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "Succinylcholine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "Enflurane may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Butabarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "Butalbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "Phenytoin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Etomidate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "Talbutal may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "Cetirizine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "Trimethadione may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Chlorzoxazone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Thiethylperazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "Dexbrompheniramine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "Metocurine iodide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "Methocarbamol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "Triprolidine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "Cyproheptadine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "Metharbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "Methohexital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "Entacapone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "Cisatracurium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "Fluticasone propionate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "Ethosuximide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "Thiopental may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "Paramethadione may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "Dyclonine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "Trimethobenzamide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "Moricizine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "Tizanidine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "Rocuronium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "Atracurium besylate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "Meclizine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "Riluzole may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "Scopolamine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "Carbinoxamine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "Isoflurane may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "Ethotoin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "Clidinium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "Oxcarbazepine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "Propiomazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "Acetazolamide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "Phensuximide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "Brompheniramine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Methylphenobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "Tiagabine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Zonisamide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Metocurine"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Emepronium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "Felbamate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Zaleplon may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Ramelteon may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "Dimenhydrinate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Guanfacine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "Methoxyflurane may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "Acetophenazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "Melatonin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Clonazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "Vigabatrin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "Levocabastine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "Methyprylon may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "Phenacemide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "Thiamylal may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "Halothane may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "Cyclizine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "Desflurane may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "Zopiclone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "Levetiracetam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "Dantrolene may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "Sevoflurane may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "Alimemazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "Fosphenytoin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "Vecuronium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "Amobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "Aprobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "Butobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "Heptabarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "Hexobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "Glutethimide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "gamma Hydroxybutyric acid may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "Barbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "Camazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "Dichloralphenazone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "Difenoxin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "Delorazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "Chlorhexadol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "Drotebanol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "Cloxazolam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "Clotiazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Chloral hydrate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "Quazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "Cinolazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "Periciazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "Thioproperazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "S Ethylisothiourea may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "Domoic Acid may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "Valpromide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "Methapyrilene may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "Urethane may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "Methaqualone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "Flunarizine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "Bifeprunox may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "Pagoclone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "Ezogabine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "Tetrodotoxin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "Methsuximide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Brivaracetam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "BL 1020 may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "Gantacurium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "Lumateperone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "Lacosamide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "Tolperisone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "Levocetirizine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "Ziconotide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "Remacemide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "Clomethiazole may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "Tramiprosate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "Ocinaplon may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "Gaboxadol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "Nitrous oxide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "Fospropofol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "Triclofos may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "Benzyl alcohol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "Mebutamate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "Sulthiame may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Gabapentin enacarbil may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "Arbaclofen Placarbil may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "Pomalidomide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "Ifenprodil may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Hexamethonium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "Eperisone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "Cyamemazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "Barbexaclone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "Beclamide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "Brotizolam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "Benzoctamine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Tasimelteon may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "Eslicarbazepine acetate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Pyrantel may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "Alfaxalone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "Doramectin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "Medetomidine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "Xylazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "Propiopromazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "Romifidine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "Tiletamine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "Tricaine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "Detomidine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "Thiocolchicoside may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "Brexanolone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "Etiracetam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "Imagabalin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "Vinpocetine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "Eltanolone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "Carisbamate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "Benzodiazepine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "AZD 3043 may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "Indiplon may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "Prothipendyl may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "Neosaxitoxin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "Valnoctamide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "Butaperazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "Apronalide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "Propanidid may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "Proxibarbal may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "Atracurium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "Febarbamate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "Trichloroethylene may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "Tetrazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "Pyrithyldione may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "Phenprobamate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "Styramate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "Pheneturide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "Bromisoval may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "Vinbarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "Chlorproethazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "Neocitrullamon may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "Acetylglycinamide chloral hydrate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "Oxypertine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "Fenyramidol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "Thiazinam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "Gedocarnil may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "Moperone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "Thiopropazate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "Emylcamate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "Allobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "Gallamine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "Diethyl ether may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "Fabomotizole may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "Pridinol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "Alcuronium may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "Hexapropymate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "Mosapramine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "Niaprazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "Vinyl ether may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "Methylpentynol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "Cyclobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "Fazadinium bromide may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "Mephenoxalone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "Vinylbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "Ethadione may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "Reposal may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "Carbromal may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "Doxefazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "Lormetazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "Cyclopropane may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "MRK 409 may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "Cannabidivarin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "Eslicarbazepine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "Perphenazine enanthate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "Oxazepam acetate may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "Cinazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "Pyrazolam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "Bentazepam may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "Triflupromazine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Desloratadine"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Palonosetron may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Metaxalone may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Sumatriptan may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Almotriptan may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Pindolol"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Promethazine"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Penbutolol"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Blonanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Tropisetron"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Phenobarbital may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "Lemborexant may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Doxepin"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "Protriptyline may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "Mephenytoin may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Dimetacrine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "Opipramol may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "Epinastine may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Maprotiline may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Leuprolide"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Goserelin"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Betaxolol"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Sulfisoxazole"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Perflutren"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Propranolol"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Atropine"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Adenosine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Gadobenic acid"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Nalidixic acid"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Cinoxacin"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lomefloxacin"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Levofloxacin"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Gemifloxacin"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Probucol"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Terlipressin"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Azimilide"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Pracinostat"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Garenoxacin"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Tedisamil"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Tucidinostat"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Telavancin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Nemonoxacin"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Antazoline"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bedaquiline"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ceritinib"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Emedastine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Encorafenib"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Maprotiline can be increased when combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Maprotiline can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The metabolism of Maprotiline can be increased when combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Caffeine"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Moxifloxacin"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Mexiletine"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Alosetron"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Gatifloxacin"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Lobeglitazone"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Pazufloxacin"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Primaquine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Quinine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Lumefantrine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Vilazodone can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The metabolism of Ritanserin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB06819",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Phenylbutyric acid"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Rucaparib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Lorcaserin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Lorpiprazole"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when Cabergoline is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Lisuride is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Ergotamine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be increased when Apomorphine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dolasetron is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Alprenolol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Granisetron is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Naratriptan"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The serum concentration of Maprotiline can be decreased when it is combined with Osimertinib"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Maprotiline can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Maprotiline can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of adverse effects can be increased when Valproic acid is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Promazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Lamotrigine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Diazepam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Perphenazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of adverse effects can be increased when Flupentixol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of adverse effects can be increased when Mesoridazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Quetiapine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Molindone"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Maprotiline may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The therapeutic efficacy of Pitolisant can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09532",
                        "description": "The therapeutic efficacy of Secretin human can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Maprotiline can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Formoterol"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Encainide"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Digitoxin"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ajmaline"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Pheniramine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Farnesyl thiopyrophosphate"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Celiprolol"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Tandutinib"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Cariporide"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Degarelix"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Buserelin"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Histrelin"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Triptorelin"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Farnesyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Geranylgeranyl diphosphate"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Chlorcyclizine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Famphur"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Phosmet"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bilastine"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Rupatadine"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Ebastine"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with CUDC 907"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Temefos"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Givinostat"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Pilsicainide"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Cibenzoline"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Prajmaline"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lorajmine"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Acetyldigoxin"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Piromidic acid"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Pipemidic acid"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Salbutamol"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Arformoterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Acrivastine"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Delafloxacin"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Fleroxacin"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Relugolix"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "Icosapent may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "Cefotiam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "Mesalazine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "Cefmenoxime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "Cefmetazole may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "Pamidronic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Indomethacin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Cidofovir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "Cefpiramide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Ceftazidime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "Loracarbef may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "Cefalotin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "Nabumetone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "Ketorolac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "Tenoxicam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "Cefotaxime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "Tolmetin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "Foscarnet may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "Piroxicam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Methotrexate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Cephalexin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "Fenoprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Valaciclovir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "Valdecoxib may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "Diclofenac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "Sulindac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "Bacitracin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "Amphotericin B may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "Cephaloglycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "Flurbiprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "Adefovir dipivoxil may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "Mannitol may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "Etodolac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "Mefenamic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Acyclovir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "Naproxen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Sulfasalazine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "Phenylbutazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "Meloxicam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "Carprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Cefaclor may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "Diflunisal may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "Etacrynic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "Ceforanide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "Salicylic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "Meclofenamic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "Carboplatin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "Oxaprozin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Hydrochlorothiazide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "Ketoprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "Balsalazide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "Ibuprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "Cefditoren may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Atazanavir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "Colistimethate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "Cefuroxime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "Cefapirin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Cefadroxil may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "Cefprozil may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Ceftriaxone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "Olsalazine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "Lumiracoxib may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "Cefamandole may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "Cefazolin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "Cefonicid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "Cefoperazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Cefotetan may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "Cefoxitin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "Ceftizoxime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Cefradine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "Magnesium salicylate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "Salsalate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "Choline magnesium trisalicylate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "Cefepime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "Cefacetrile may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Ceftibuten may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "Cefpodoxime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "Antrafenine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "Aminophenazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "Antipyrine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "Tiaprofenic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "Etoricoxib may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "Hydrolyzed Cephalothin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "Cephalothin Group may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "Oxyphenbutazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "Latamoxef may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "Nimesulide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "Benoxaprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "Metamizole may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "Zomepirac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "Ceftobiprole may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "Cimicoxib may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "Ceftaroline fosamil may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "Lornoxicam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "Aceclofenac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "Zaltoprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "Azapropazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "Parecoxib may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "Salicylamide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "Kebuzone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "Isoxicam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "Indoprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "Ibuproxam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "Floctafenine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "Fenbufen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "Etofenamate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "Epirizole may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "Cefaloridine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "Cefminox may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "Benzydamine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "Dexibuprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "Dexketoprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "Droxicam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "Tolfenamic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "Firocoxib may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "Clonixin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "Morniflumate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Propacetamol may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "Talniflumate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Cefroxadine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "Robenacoxib may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "Tepoxalin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "Flunixin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "Flomoxef may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Brincidofovir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "Nitroaspirin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "Indobufen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "Tinoridine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "Alclofenac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "Fentiazac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "Suxibuzone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "Cefatrizine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "Bumadizone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "Alminoprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "Difenpiramide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "Nifenazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "Lonazolac may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "Cefcapene may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "Cefodizime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "Tenidap may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "Cefsulodin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "Cefetamet may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "Propyphenazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "Proglumetacin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "Guacetisal may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "Ethenzamide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "Carbaspirin calcium may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "Mofebutazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "Cefbuperazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "Proquazone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "Benorilate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "Cefozopran may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "Cefpirome may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "Pirprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "Cefazedone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "Acemetacin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "Ceftezole may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "Imidazole salicylate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "Adefovir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "SC 236 may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "NS 398 may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "Inotersen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Phenazopyridine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "Lopinavir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "Loxoprofen may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "Framycetin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "Paromomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "Geneticin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "Apramycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "Neamine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "Puromycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "Dihydrostreptomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "Hygromycin B may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Maprotiline may decrease the excretion rate of Lubiprostone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Maprotiline may decrease the excretion rate of Sorbitol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "Maprotiline may decrease the excretion rate of Prucalopride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Maprotiline may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Maprotiline may decrease the excretion rate of Bisoxatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Maprotiline may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Maprotiline may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Maprotiline may decrease the excretion rate of Sodium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Maprotiline may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Maprotiline may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Salmon calcitonin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Desmopressin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Aldesleukin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Daptomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "Tositumomab may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Cyanocobalamin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Folic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Pyridoxine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Cevimeline may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Carbidopa may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Oseltamivir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Hydroxocobalamin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Gadodiamide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Milrinone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Doxycycline may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Diatrizoate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Liothyronine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Acarbose may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Bleomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Etonogestrel may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Ertapenem may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Piperacillin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Floxuridine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Nitroprusside may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Ethambutol may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Metformin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Pyrazinamide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Megestrol acetate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Aztreonam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Sulfadiazine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Sucralfate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Dexrazoxane may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Ampicillin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Methylphenidate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Trifluridine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Allopurinol may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Trimethoprim may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "Gemcitabine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Lenalidomide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Fosinopril may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Cefdinir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Azelaic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Zanamivir may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Fondaparinux may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Levocarnitine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "Fluocinolone acetonide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Gadoteridol may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Medroxyprogesterone acetate may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Bisoprolol may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Testosterone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Clofarabine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "Prednisone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Dyphylline may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Mecamylamine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Nilutamide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Chlorpropamide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Mycophenolate mofetil may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Phentolamine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Tamsulosin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lamivudine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Oxacillin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Nedocromil may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Lisinopril may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Nateglinide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Pralidoxime may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Tetracycline may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Meropenem may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Tirofiban may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Gadopentetic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Fenoldopam may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Ribavirin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Tadalafil may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Fosfomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Tolazamide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Dobutamine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Temozolomide may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Testolactone may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Didanosine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Tinidazole may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Azacitidine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Maprotiline may decrease the excretion rate of Mepivacaine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Maprotiline may decrease the excretion rate of Methyldopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Maprotiline may decrease the excretion rate of Dopamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Maprotiline may decrease the excretion rate of Auranofin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Maprotiline may decrease the excretion rate of Ganciclovir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Maprotiline may decrease the excretion rate of Metyrapone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Maprotiline may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Maprotiline may decrease the excretion rate of Phylloquinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Maprotiline may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Maprotiline may decrease the excretion rate of Topotecan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Maprotiline may decrease the excretion rate of Probenecid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Maprotiline may decrease the excretion rate of Fenofibrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Maprotiline may decrease the excretion rate of Abacavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Maprotiline may decrease the excretion rate of Amoxicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Maprotiline may decrease the excretion rate of Glipizide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Maprotiline may decrease the excretion rate of Flucytosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Maprotiline may decrease the excretion rate of Capecitabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Maprotiline may decrease the excretion rate of Tolbutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Maprotiline may decrease the excretion rate of Tiludronic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Maprotiline may decrease the excretion rate of Trimetrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Maprotiline may decrease the excretion rate of Guanethidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "Maprotiline may decrease the excretion rate of Ifosfamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Maprotiline may decrease the excretion rate of Naloxone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Maprotiline may decrease the excretion rate of Nadolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Maprotiline may decrease the excretion rate of Flumazenil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Maprotiline may decrease the excretion rate of Fomepizole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Maprotiline may decrease the excretion rate of Budesonide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Maprotiline may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Maprotiline may decrease the excretion rate of Iodixanol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Maprotiline may decrease the excretion rate of Sitagliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Maprotiline may decrease the excretion rate of Varenicline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Maprotiline may decrease the excretion rate of Hydralazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "Maprotiline may decrease the excretion rate of Colchicine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Maprotiline may decrease the excretion rate of Testosterone propionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Maprotiline may decrease the excretion rate of Amrinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Maprotiline may decrease the excretion rate of Oxybenzone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Maprotiline may decrease the excretion rate of Allylestrenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Maprotiline may decrease the excretion rate of Fenproporex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Maprotiline may decrease the excretion rate of Valganciclovir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Maprotiline may decrease the excretion rate of Roflumilast which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Maprotiline may decrease the excretion rate of Topiroxostat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Maprotiline may decrease the excretion rate of Pegaptanib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Maprotiline may decrease the excretion rate of Clevidipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Maprotiline may decrease the excretion rate of Migalastat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Maprotiline may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Maprotiline may decrease the excretion rate of Ipilimumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Maprotiline may decrease the excretion rate of Icatibant which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Maprotiline may decrease the excretion rate of Alogliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Maprotiline may decrease the excretion rate of Prasugrel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Maprotiline may decrease the excretion rate of Doripenem which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Maprotiline may decrease the excretion rate of Rivaroxaban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Maprotiline may decrease the excretion rate of Nalmefene which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Maprotiline may decrease the excretion rate of Droxidopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Maprotiline may decrease the excretion rate of Saxagliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Maprotiline may decrease the excretion rate of Flupirtine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Maprotiline may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Maprotiline may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Maprotiline may decrease the excretion rate of Methyltestosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Maprotiline may decrease the excretion rate of Ammonium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Maprotiline may decrease the excretion rate of Dimercaprol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Maprotiline may decrease the excretion rate of Mangafodipir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Maprotiline may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Maprotiline may decrease the excretion rate of Plerixafor which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Maprotiline may decrease the excretion rate of Pralatrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Maprotiline may decrease the excretion rate of Tiopronin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Maprotiline may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Maprotiline may decrease the excretion rate of Ioflupane I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Maprotiline may decrease the excretion rate of Deferiprone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "Maprotiline may decrease the excretion rate of N methylnicotinamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Maprotiline may decrease the excretion rate of Ruxolitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Maprotiline may decrease the excretion rate of Peginesatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Maprotiline may decrease the excretion rate of Teduglutide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Maprotiline may decrease the excretion rate of Formestane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Maprotiline may decrease the excretion rate of Trametinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Maprotiline may decrease the excretion rate of Macitentan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Maprotiline may decrease the excretion rate of Sofosbuvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Maprotiline may decrease the excretion rate of Ledipasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Maprotiline may decrease the excretion rate of Ceftolozane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Maprotiline may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "Maprotiline may decrease the excretion rate of Edoxaban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Maprotiline may decrease the excretion rate of Idebenone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "Maprotiline may decrease the excretion rate of Tixocortol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Maprotiline may decrease the excretion rate of Ancestim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Maprotiline may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Maprotiline may decrease the excretion rate of Pentastarch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Maprotiline may decrease the excretion rate of Aurothioglucose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Maprotiline may decrease the excretion rate of Dienogest which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Maprotiline may decrease the excretion rate of Chromic chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Maprotiline may decrease the excretion rate of Gadoteric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Maprotiline may decrease the excretion rate of Iothalamic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Maprotiline may decrease the excretion rate of Ioversol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Maprotiline may decrease the excretion rate of Ioxilan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Maprotiline may decrease the excretion rate of Isosulfan blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Maprotiline may decrease the excretion rate of Technetium Tc 99m mebrofenin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Maprotiline may decrease the excretion rate of Technetium Tc 99m oxidronate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Maprotiline may decrease the excretion rate of Florbetaben 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Maprotiline may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Maprotiline may decrease the excretion rate of Iopromide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Maprotiline may decrease the excretion rate of Technetium Tc 99m exametazime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Maprotiline may decrease the excretion rate of Technetium Tc 99m pyrophosphate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Maprotiline may decrease the excretion rate of Arotinolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Maprotiline may decrease the excretion rate of Moxisylyte which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Maprotiline may decrease the excretion rate of Pholcodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Maprotiline may decrease the excretion rate of Piracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Maprotiline may decrease the excretion rate of Nicorandil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Maprotiline may decrease the excretion rate of Dextran which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Maprotiline may decrease the excretion rate of Gimeracil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Maprotiline may decrease the excretion rate of Idarucizumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Maprotiline may decrease the excretion rate of Lixisenatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Maprotiline may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Maprotiline may decrease the excretion rate of Choline C 11 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Maprotiline may decrease the excretion rate of Sacubitril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Maprotiline may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Maprotiline may decrease the excretion rate of Synthetic Conjugated Estrogens A which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Maprotiline may decrease the excretion rate of Synthetic Conjugated Estrogens B which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Maprotiline may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Maprotiline may decrease the excretion rate of Sulbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Maprotiline may decrease the excretion rate of Sodium fluoride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Maprotiline may decrease the excretion rate of Antihemophilic Factor Recombinant PEGylated which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Maprotiline may decrease the excretion rate of Invert sugar which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Maprotiline may decrease the excretion rate of Dexpanthenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Maprotiline may decrease the excretion rate of Phosphoric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Maprotiline may decrease the excretion rate of Sodium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Maprotiline may decrease the excretion rate of Magnesium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Maprotiline may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Maprotiline may decrease the excretion rate of Enalaprilat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Maprotiline may decrease the excretion rate of Octinoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Maprotiline may decrease the excretion rate of Fludeoxyglucose 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Maprotiline may decrease the excretion rate of Iobenguane sulfate I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Maprotiline may decrease the excretion rate of Ixazomib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Maprotiline may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Maprotiline may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Maprotiline may decrease the excretion rate of N acetyltyrosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Maprotiline may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Maprotiline may decrease the excretion rate of Selenious acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Maprotiline may decrease the excretion rate of Selenium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Maprotiline may decrease the excretion rate of Chromium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Maprotiline may decrease the excretion rate of Oxyquinoline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Maprotiline may decrease the excretion rate of Bicisate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Maprotiline may decrease the excretion rate of Tocopherol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Maprotiline may decrease the excretion rate of DL Methylephedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Maprotiline may decrease the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Maprotiline may decrease the excretion rate of Clove oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Maprotiline may decrease the excretion rate of Evening primrose oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Maprotiline may decrease the excretion rate of Pidotimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Maprotiline may decrease the excretion rate of Lesinurad which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Maprotiline may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Maprotiline may decrease the excretion rate of Etafedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Maprotiline may decrease the excretion rate of Antithrombin III human which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Maprotiline may decrease the excretion rate of Naldemedine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Maprotiline may decrease the excretion rate of Baricitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Maprotiline may decrease the excretion rate of Apalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Maprotiline may decrease the excretion rate of Valbenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Maprotiline may decrease the excretion rate of Benznidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Maprotiline may decrease the excretion rate of Isoflavone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Maprotiline may decrease the excretion rate of Vaborbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Maprotiline may decrease the excretion rate of Benserazide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Maprotiline may decrease the excretion rate of Inosine pranobex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Maprotiline may decrease the excretion rate of Inositol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Maprotiline may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Maprotiline may decrease the excretion rate of Phosphocreatine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Maprotiline may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Maprotiline may decrease the excretion rate of Ipecac which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Maprotiline may decrease the excretion rate of Almasilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Maprotiline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Maprotiline may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Maprotiline may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Maprotiline may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Maprotiline may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Maprotiline may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Maprotiline may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Maprotiline may decrease the excretion rate of Choline salicylate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Maprotiline may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Maprotiline may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Maprotiline may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Maprotiline may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Maprotiline may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Maprotiline may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Maprotiline may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Maprotiline may decrease the excretion rate of Pyrithione which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Maprotiline may decrease the excretion rate of Chloroxylenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "Maprotiline may decrease the excretion rate of Enzalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Maprotiline may decrease the excretion rate of Resorcinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Maprotiline may decrease the excretion rate of Potassium nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Maprotiline may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Emtricitabine may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Maprotiline may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Perindopril may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Maprotiline may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Maprotiline may decrease the excretion rate of Bepotastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Maprotiline may decrease the excretion rate of Isotretinoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Maprotiline may decrease the excretion rate of Permethrin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "Maprotiline may decrease the excretion rate of Difluocortolone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Cisplatin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Maprotiline may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "Neomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Ribostamycin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Gentamicin C1a may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Arbekacin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Sisomicin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Isepamicin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Pentostatin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Maprotiline may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Maprotiline may decrease the excretion rate of Capreomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Maprotiline may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Maprotiline may decrease the excretion rate of Vancomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Maprotiline may decrease the excretion rate of Pemetrexed which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Maprotiline may decrease the excretion rate of Warfarin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Maprotiline may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Maprotiline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Maprotiline may increase the excretion rate of Methyclothiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Maprotiline may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Maprotiline may increase the excretion rate of Bendroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Maprotiline may increase the excretion rate of Benzthiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Maprotiline may increase the excretion rate of Hydroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Maprotiline may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Maprotiline may increase the excretion rate of Trichlormethiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Maprotiline may increase the excretion rate of Polythiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Maprotiline may increase the excretion rate of Quinethazone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Maprotiline may increase the excretion rate of Cyclopenthiazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Maprotiline may increase the excretion rate of Epitizide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Maprotiline may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Maprotiline may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Metolazone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Furosemide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Indapamide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Bumetanide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Maprotiline may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Maprotiline may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cyclothiazide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Eplerenone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "Conivaptan may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "Tolvaptan may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Potassium citrate may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "Isosorbide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Ertugliflozin may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "Mebutizide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Muzolimine may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Xipamide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Maprotiline may increase the excretion rate of Potassium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Felodipine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Dimethyl sulfoxide can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00792",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Tripelennamine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Biperiden"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Vernakalant"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Sparteine"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Naloxegol"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Artenimol"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB01096",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Oxamniquine"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB01562",
                        "description": "The metabolism of Maprotiline can be decreased when combined with 1 2 Phenylethyl 4 phenyl 4 acetoxypiperidine"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Nevirapine"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Proguanil"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Ospemifene"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Bupivacaine"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Atenolol"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Piperazine"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Nicergoline"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Phenformin"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Idarubicin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Bevantolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The metabolism of Practolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Aprindine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Nebivolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Tafenoquine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Bufuralol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Bopindolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The metabolism of Landiolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The metabolism of Tertatolol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Ciclesonide can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The metabolism of Sotalol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The metabolism of Procainamide can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Flecainide can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The metabolism of Maprotiline can be increased when combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The metabolism of Maprotiline can be increased when combined with Capsaicin"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Rabeprazole can be increased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00030",
                        "description": "The metabolism of Maprotiline can be increased when combined with Insulin human"
                    },
                    {
                        "drugbank-id": "DB00046",
                        "description": "The metabolism of Maprotiline can be increased when combined with Insulin lispro"
                    },
                    {
                        "drugbank-id": "DB00047",
                        "description": "The metabolism of Maprotiline can be increased when combined with Insulin glargine"
                    },
                    {
                        "drugbank-id": "DB00071",
                        "description": "The metabolism of Maprotiline can be increased when combined with Insulin pork"
                    },
                    {
                        "drugbank-id": "DB00170",
                        "description": "The metabolism of Maprotiline can be increased when combined with Menadione"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The metabolism of Maprotiline can be increased when combined with Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The metabolism of Maprotiline can be increased when combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00607",
                        "description": "The metabolism of Maprotiline can be increased when combined with Nafcillin"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Maprotiline can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB01309",
                        "description": "The metabolism of Maprotiline can be increased when combined with Insulin glulisine"
                    },
                    {
                        "drugbank-id": "DB05115",
                        "description": "The metabolism of Maprotiline can be increased when combined with NN344"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The metabolism of Maprotiline can be increased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Maprotiline can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB06732",
                        "description": "The metabolism of Maprotiline can be increased when combined with beta Naphthoflavone"
                    },
                    {
                        "drugbank-id": "DB09564",
                        "description": "The metabolism of Maprotiline can be increased when combined with Insulin degludec"
                    },
                    {
                        "drugbank-id": "DB11567",
                        "description": "The metabolism of Maprotiline can be increased when combined with Insulin peglispro"
                    },
                    {
                        "drugbank-id": "DB11568",
                        "description": "The metabolism of Maprotiline can be increased when combined with Insulin tregopil"
                    },
                    {
                        "drugbank-id": "DB09456",
                        "description": "The metabolism of Insulin beef can be increased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Maprotiline can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Maprotiline can be increased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon alfa n1"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon alfa n3"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon gamma 1b"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon alfa 2a Recombinant"
                    },
                    {
                        "drugbank-id": "DB00060",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon beta 1b"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Nitric Oxide"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Pefloxacin"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Methoxsalen"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Thiabendazole"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Rosoxacin"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Resveratrol"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Estrone sulfate"
                    },
                    {
                        "drugbank-id": "DB05396",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Albinterferon Alfa 2B"
                    },
                    {
                        "drugbank-id": "DB05990",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Obeticholic acid"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB06803",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Niclosamide"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Flumequine"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB11198",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Peppermint oil"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Enrofloxacin"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Orbifloxacin"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Sarafloxacin"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Difloxacin"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Prulifloxacin"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Oxolinic acid"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Rufloxacin"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Estradiol acetate"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Estradiol benzoate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Estradiol cypionate"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Estradiol dienanthate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Estradiol valerate"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB15119",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Ropeginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB15131",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon alfa 2c"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Tacrine"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Pentoxifylline"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Nicotine"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Carmustine"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Conjugated estrogens"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Ropivacaine"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Zolmitriptan"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Triamterene"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00442",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Entecavir"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Flutamide"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Albendazole"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00744",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Zileuton"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Clopidogrel"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Dacarbazine"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The metabolism of Azathioprine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The metabolism of Frovatriptan can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "The metabolism of Levobupivacaine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01056",
                        "description": "The metabolism of Tocainide can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01058",
                        "description": "The metabolism of Praziquantel can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "The metabolism of Hesperetin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Carvedilol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Dexfenfluramine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The metabolism of Oxtriphylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The metabolism of Theobromine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The metabolism of Acenocoumarol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The metabolism of Fenethylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Genistein can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The metabolism of 8 azaguanine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The metabolism of Xanthine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The metabolism of 9 Methylguanine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The metabolism of Peldesine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The metabolism of Hypoxanthine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The metabolism of 9 Deazaguanine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Eltrombopag can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06235",
                        "description": "The metabolism of Vadimezan can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The metabolism of Propentofylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The metabolism of Agomelatine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The metabolism of Bendamustine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The metabolism of R warfarin can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The metabolism of Doxofylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The metabolism of 6 O benzylguanine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11967",
                        "description": "The metabolism of Binimetinib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The metabolism of Voxilaprevir can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The metabolism of Lisofylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The metabolism of Lobucavir can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The metabolism of Cafedrine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The metabolism of Theodrenaline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The metabolism of Bamifylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The metabolism of Proxyphylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The metabolism of Acefylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The metabolism of Etamiphylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The metabolism of Pentifylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The metabolism of Bufylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The metabolism of Bromotheophylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The metabolism of 8 chlorotheophylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB05708",
                        "description": "The metabolism of GTS 21 can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Estradiol"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The metabolism of Ethinylestradiol can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The metabolism of Selumetinib can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Estrone"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The metabolism of Pirfenidone can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00299",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Penciclovir"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The metabolism of Quinidine can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Enoxacin"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Technetium Tc 99m ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB14025",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Clinafloxacin"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "The metabolism of Maprotiline can be decreased when combined with Furafylline"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB08167",
                        "description": "The risk or severity of serotonin syndrome can be increased when Maprotiline is combined with Methylthioninium"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "The risk or severity of serotonin syndrome can be increased when Maprotiline is combined with Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The absorption of Levodopa can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The therapeutic efficacy of Cenobamate can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "Maprotiline may increase the anticholinergic activities of Loratadine"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of seizure can be increased when Maprotiline is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Maprotiline can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Maprotiline can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Maprotiline can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Maprotiline can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Maprotiline can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Maprotiline can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Maprotiline can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Maprotiline can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Maprotiline can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Maprotiline can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Maprotiline can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Maprotiline can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Maprotiline can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Maprotiline can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Maprotiline can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The risk or severity of Tachycardia can be increased when Bethanidine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The risk or severity of Tachycardia can be increased when Isoetharine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The risk or severity of Tachycardia can be increased when Metaraminol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The risk or severity of Tachycardia can be increased when Epinephrine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The risk or severity of Tachycardia can be increased when Methoxamine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of Tachycardia can be increased when Phenmetrazine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The risk or severity of Tachycardia can be increased when Ritodrine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The risk or severity of Tachycardia can be increased when Bitolterol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Arbutamine"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Pirbuterol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Ephedra sinica root"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Phendimetrazine"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Amibegron"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Solabegron"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Protokylol"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Synephrine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Moxonidine"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Amitraz"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Reproterol"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Octopamine"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Xamoterol"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of Tachycardia can be increased when Maprotiline is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The risk or severity of Tachycardia can be increased when Midodrine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The therapeutic efficacy of Domperidone can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The therapeutic efficacy of Macimorelin can be decreased when used in combination with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Maprotiline is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The therapeutic efficacy of Maprotiline can be decreased when used in combination with Donepezil"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "The risk or severity of seizure can be increased when Maprotiline is combined with Dalfampridine"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Maprotiline is combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of serotonin syndrome can be increased when Maprotiline is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Dronedarone can be decreased when combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of serotonin syndrome can be increased when Maprotiline is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Maprotiline can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The risk or severity of adverse effects can be increased when Levothyroxine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of seizure can be increased when Maprotiline is combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Maprotiline can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Maprotiline can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of sedation can be increased when Remimazolam is combined with Maprotiline"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Maprotiline can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Maprotiline is combined with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Maprotiline can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}